APRIL 13-16, 2019
29TH ECCMID IN AMSTERDAM, HOLLAND
Dr. Michel Pieren will be presenting at the ECCMID 2019, the 29th European Congress of Clinical Microbiology and Infectious Diseases this year.
Date and Time: April 15th at 4pm;
Session: Pathogenesis and treating of persistent staphylococcal infection
Session room: HALL I;
The title of his presentation is: Inhibition of AgrA-mediated virulence factor expression in MRSA reduced disease severity of skin and soft tissue infections
Please see the conference information here
MARCH 18-20, 2019
SMI SUPERBUGS AND SUPERDRUGS, LONDON, UK
Join Dr. Sergio Lociuro at the SMi Superbugs and Superdrugs Conference in London, UK. He will be presenting on March 19th at 11:40!
This year’s event will gather leaders from pharmaceutical companies, academia and the wider scientific community together with regulatory agencies and public-private partnerships, to discuss the growing threat of antibiotic resistance.
The event will also focus on the strategies pharmaceutical companies use to assist the development of new therapeutics & drugs, how to obtain funding for new projects and address why there is a current lack of incentives for researchers working in antimicrobial resistance research and development.
MARCH 14-15, 2019
12TH BERLIN CONFERENCE ON LIFE SCIENCES
Meet and hear from our new Chief Development Officer Dr. Glenn Dale, Dr. Marc Gitzinger (CEO) and Dr. Jonathan Butcher (Head BD) in Berlin March 14th-15th at the BIOCOM Antimicrobial conference – hear about the latest trends in AMR R&D and Policy, and why AMR is a strong investment opportunity for VCs and private investors.
11am March 15th Glenn will present during Session 3: Clinical Development & Regulation
2pm March 15th Marc will present during Session 6: Therapeutics (human)
Conference information here